Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 60 Degrees, Acelyrin, Arcturus, Axcella, Capricor, Douglas, Eiger, Eucure, Geovax, Glaxosmithkline, HDT, Jiangsu Hengrui, Inmagene, Merck, Nicox, Novaliq, Nrx, Nykode, Pfizer, Recce, Ridgeback, Sanofi, Valneva.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aeromics, Astrazeneca, Bavarian Nordic, Beigene, Catalyst, Cyxone, Daiichi Sankyo, Dydo, Eucure, Glaxosmithkline, Henlius, Hutchmed, I-Mab, Implicit, Innovent, Johnson & Johnson, Kazia, Medicago, Nrx, Quantum Leap, Recce, Samsung Bioepis, Sciwind, Simcere, Takeda, Zymeworks.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: AB Science, Adagene, Anji, Arca, Arch Biopartners, Astrazeneca, Betterlife, Bonus Biogroup, Daiichi Sankyo, First Wave, Hepagene, Humanigen, Hummingbird, I-Mab, Immutep, Insilico Medicine Hong Kong, Kyowa Kirin, Lintonpharm, Longeveron, Lynk, Mei, Merck, Nrx, Ose Immunotherapeutics, Pulmotect, RDIF, Revive, Ridgeback, Starpharma, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akston, Arctic Vision, Astrazeneca, Beigene, Biontech, Daiichi Sankyo, Hutchmed, Innovent, Oncotelic, Pfizer, Pulmonem, Syneurx, Tennor.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Daiichi Sankyo, Connect, Gannex, Immutep, Innovation, Kancera, Molecular Partners, Oncolys, Tevogen, Todos.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Addex, Affimed, Appili, Ascletis, Beigene, Bioarctic, Biogen, Biophytis, Clarity, Eisai, Emergex Vaccines Holding, Glaxosmithkline, Gmax, Helixmith, Immutep, Innovent Biologics, Janssen, Kazia, Kintor, Nkgen Biotech, Noxopharm, Pneumagen, Recbio Technology, Redhill, Regeneron, Ribomic, Sinovac, Suzhou Alphamab, Synairgen, Urovant Sciences, Vir, Zymeworks.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aribio, Chinook, Innovation, Kazia, Kintor, Macrogenics, Nrx, Pfizer, RDIF, Sumitomo Dainippon, Vicore.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: ABVC, Alphamab Oncology, Anheart, Arca, Astrazeneca, Canbridge, Cytodyn, Daiichi Sankyo, Hutchmed, Innovent Biologics, Meissa Vaccines, Moderna, Novatek, Olipass, Revive, Sorrento, Todos Medical, Vaxart, Vicore.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Alphamab Oncology, Alterity, Atea, Biontech, Bridge, Cardiol, Crescendo Biologics, Edesa, Entasis, Genfleet, Harbour Biomed, Helixmith, Immune Biosolutions, Opthea, Pfizer, Reven, Senhwa, Statera, Synairgen, Telix, Valneva, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 60 Degrees, Adlai Nortye, Advaccine, Akeso, Apeiron, Arcturus, Ascletis, Astellas, Astrazeneca, Gan & Lee, I-Mab, Inflarx, Inovio, Medigen Vaccine Biologics, Neurobo, Oncolytics, RDIF, Reistone, Resverlogix, TC Biopharm, Westvac.